SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical–protein interactome-Reference-Cited by-同舟云学术

SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical–protein interactome

Published:2009-05-05 Issue:suppl_2 Volume:37 Page:W406-W412
ISSN:1362-4962
Container-title:Nucleic Acids Research
language:en
Short-container-title:

Author:

Yang Lun,Luo Heng,Chen Jian,Xing Qinghe,He Lin

Publisher

Oxford University Press (OUP)

Subject

Genetics

Link

http://academic.oup.com/nar/article-pdf/37/suppl_2/W406/16757869/gkp312.pdf

Reference28 articles.

1. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected];Fukuoka;J. Clin. Oncol.,2003

2. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N. Engl. J. Med.,2004

3. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

4. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib;Kobayashi;N. Engl. J. Med.,2005

5. Adverse cardiovascular effects of rofecoxib;Furberg;N. Engl. J. Med.,2006

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network medicine and systems pharmacology approaches to predicting adverse drug effects;British Journal of Pharmacology;2024-09-11

2. Schizandrin A induces non‐small cell lung cancer apoptosis by suppressing the epidermal growth factor receptor activation;Cancer Medicine;2024-01

3. Emerging Machine Learning Techniques in Predicting Adverse Drug Reactions;Machine Learning and Deep Learning in Computational Toxicology;2023

4. Molecular Docking: Principles, Advances, and its Applications in Drug Discovery;Letters in Drug Design & Discovery;2022-09-22

5. The Use of AlphaFold for In Silico Exploration of Drug Targets in the Parasite Trypanosoma cruzi;Frontiers in Cellular and Infection Microbiology;2022-07-14